Tat-functionalized liposomes for the treatment of meningitis: an in vitro study

Area of Science:

• Nanotechnology in Medicine
• Infectious Diseases
• Bacterial Pathogenesis

Background:

• Emergence of antibiotic-resistant bacteria poses a global health threat, particularly in bacterial meningitis.
• Liposomes offer potential for intracellular drug delivery into bacteria, a novel therapeutic strategy.
• Fusogenic liposomes enhance bacterial membrane fusion and intracellular drug release, with CPPs further improving this efficiency.

Purpose of the Study:

• To evaluate the efficacy of novel fusogenic liposomes loaded with antibiotics and functionalized with Tat47-57 peptide against key meningitis-causing bacteria.
• To demonstrate the in vitro antibacterial activity of these Tat-functionalized liposomes against Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Escherichia coli.
• To assess the safety profile of these liposomes by performing cytotoxicity tests on blood-brain barrier cells.

Main Methods:

• Preparation of spherical fusogenic liposomes (100 nm diameter) loaded with vancomycin, methicillin, or ampicillin.
• Functionalization of liposomes with the cell-penetrating peptide Tat47-57.
• Assessment of antibacterial activity using colony-forming unit counts, growth-curve assays, and live/dead assays with fluorescence microscopy.
• Cytotoxicity evaluation on astrocytes and endothelial cells.

Main Results:

• Tat-functionalized liposomes significantly reduced the minimum inhibitory concentration of loaded antibiotics against all tested bacteria.
• Complete eradication of bacterial populations was achieved with Tat-functionalized liposomes loaded with methicillin at concentrations of 1.7-3 µg/mL.
• Cytotoxicity assays indicated promising safety profiles for the liposomes and the Tat peptide on blood-brain barrier cells.

Conclusions:

• The developed Tat-functionalized fusogenic liposomes represent a promising novel drug delivery system for combating antibiotic-resistant bacterial meningitis.
• These liposomes demonstrate enhanced antibacterial efficacy and a favorable safety profile, warranting further investigation for clinical application.
• The study highlights the potential of CPP-functionalized liposomes in overcoming bacterial resistance mechanisms and improving treatment outcomes for severe infections.